» Articles » PMID: 35534848

Use of Preventive Measures and Serological Screening Tools for Leishmania Infantum Infection in Dogs from Europe

Overview
Journal Parasit Vectors
Publisher Biomed Central
Date 2022 May 9
PMID 35534848
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There are several screening tools for detecting Leishmania infantum infection in dogs and various preventive measures to protect against it. Some studies have investigated them, but not many have described their current use. The aim of this study was to investigate which preventive measures and serological screening tools for L. infantum infection were employed from 2012 to 2018 in dogs from different endemic European countries.

Methods: A set of electronic datasheets was completed for each dog from several veterinary centres. Classification of preventive measures included: (1) repellents, (2) vaccines and (3) immunomodulators. Classification of serological tests included the: (1) direct agglutination test (DAT), (2) enzyme-linked immunosorbent assay (ELISA), (3) indirect immunofluorescence (IFI), (4) rapid tests and (5) other assays. Dogs were also classified depending on their risk of exposure and living area.

Results: Information from 3762 dogs was gathered. Preventive measures were applied in 91.5% of dogs and the most frequently used were repellents (86.2%) followed by vaccines (39.8%) and Leisguard (15.3%). The different types of repellents (collar and spot-on) were used similarly. A combination of a vaccine and repellents was preferred in the high-risk group while the low-risk preferred a combination of Leisguard and a repellent (Chi-square test: X = 88.41, df = 10, P < 0.001). Furthermore, all preventive measures were similarly used through the years except for repellents, which were predicted to have a small increase of use each year. Regarding serological screening tools, the most used were rapid and ELISA tests. Rapid tests, ELISA tests and DAT were used similarly through the years, but a significant change was found in the use of IFI and other assays whose use decreased a little each year.

Conclusions: Repellents were the preferred measure, while vaccines and Leisguard were second-line options. Some dogs were not treated by any measures, which highlights the need for dog owner education. Moreover, there seems to be a preference for rapid tests in the clinical setting to detect specific L. infantum antibodies while ELISA or IFI are less often employed. This underlines an increasing problem, as qualitative rapid tests have a variable diagnostic performance limiting the adequate diagnosis of seropositive dogs in endemic areas.

Citing Articles

Twenty-year evolution of Leishmania infantum infection in dogs in Valdeorras (Galicia, Northwestern Spain): implication of climatic factors and preventive measures.

Olmeda P, Diaz-Reganon D, Villaescusa A, Amusategui I, Garcia A, Herrero F Parasit Vectors. 2024; 17(1):281.

PMID: 38951858 PMC: 11218365. DOI: 10.1186/s13071-024-06357-8.


New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine.

Oliveira D, Zaldivar M, Goncalves A, Resende L, Mariano R, Pereira D Vaccines (Basel). 2024; 12(3).

PMID: 38543905 PMC: 10975552. DOI: 10.3390/vaccines12030271.


A 10-Year Retrospective Study on Pediatric Visceral Leishmaniasis in a European Endemic Area: Diagnostic and Short-Course Therapeutic Strategies.

Dondi A, Manieri E, Gambuti G, Varani S, Campoli C, Zama D Healthcare (Basel). 2024; 12(1).

PMID: 38200929 PMC: 10779246. DOI: 10.3390/healthcare12010023.


Knock, knock, knocking on Europes door: Threat of leishmaniasis in Europe with a focus on Turkey.

Tunali V, Ozbilgin A Curr Res Parasitol Vector Borne Dis. 2023; 4:100150.

PMID: 37941928 PMC: 10628545. DOI: 10.1016/j.crpvbd.2023.100150.


Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges.

Leite J, Goncalves A, Oliveira D, Resende L, Boas D, Ribeiro H Vaccines (Basel). 2023; 11(10).

PMID: 37896969 PMC: 10610753. DOI: 10.3390/vaccines11101565.


References
1.
Baneth G, Koutinas A, Solano-Gallego L, Bourdeau P, Ferrer L . Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 2008; 24(7):324-30. DOI: 10.1016/j.pt.2008.04.001. View

2.
de Freitas E, Melo M, da Costa-Val A, Michalick M . Transmission of Leishmania infantum via blood transfusion in dogs: potential for infection and importance of clinical factors. Vet Parasitol. 2006; 137(1-2):159-67. DOI: 10.1016/j.vetpar.2005.12.011. View

3.
Fernandez M, Tabar M, Arcas A, Mateu C, Homedes J, Roura X . Comparison of efficacy and safety of preventive measures used against canine leishmaniasis in southern European countries: Longitudinal retrospective study in 1647 client-owned dogs (2012-2016). Vet Parasitol. 2018; 263:10-17. DOI: 10.1016/j.vetpar.2018.09.014. View

4.
Rosypal A, Troy G, Zajac A, Frank G, Lindsay D . Transplacental transmission of a North American isolate of Leishmania infantum in an experimentally infected beagle. J Parasitol. 2006; 91(4):970-2. DOI: 10.1645/GE-483R.1. View

5.
Dostalova A, Volf P . Leishmania development in sand flies: parasite-vector interactions overview. Parasit Vectors. 2012; 5:276. PMC: 3533922. DOI: 10.1186/1756-3305-5-276. View